Terms: = Thyroid cancer AND TPM3, ENSG00000143549, 7170 AND Treatment
6 results:
1. Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation.
Yan W; Zhang L; Lv F; Moccia M; Carlomagno F; Landry C; Santoro M; Gosselet F; Frett B; Li HY
Eur J Med Chem; 2021 Apr; 216():113265. PubMed ID: 33652352
[TBL] [Abstract] [Full Text] [Related]
2. U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors.
Papadopoulos KP; Borazanci E; Shaw AT; Katayama R; Shimizu Y; Zhu VW; Sun TY; Wakelee HA; Madison R; Schrock AB; Senaldi G; Nakao N; Hanzawa H; Tachibana M; Isoyama T; Nakamaru K; Deng C; Li M; Fan F; Zhao Q; Gao Y; Seto T; Jänne PA; Ou SI
Clin Cancer Res; 2020 Sep; 26(18):4785-4794. PubMed ID: 32591465
[TBL] [Abstract] [Full Text] [Related]
3. Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma.
van der Tuin K; Ventayol Garcia M; Corver WE; Khalifa MN; Ruano Neto D; Corssmit EPM; Hes FJ; Links TP; Smit JWA; Plantinga TS; Kapiteijn E; van Wezel T; Morreau H
Eur J Endocrinol; 2019 Apr; 180(4):235-241. PubMed ID: 30668525
[TBL] [Abstract] [Full Text] [Related]
4. Surgical treatment of 21 patients with spinal metastases of differentiated thyroid cancer.
Jiang L; Ouyang H; Liu X; Wei F; Wu F; Dang L; Liu Z
Chin Med J (Engl); 2014; 127(23):4092-6. PubMed ID: 25430455
[TBL] [Abstract] [Full Text] [Related]
5. ALKoma: a cancer subtype with a shared target.
Mano H
Cancer Discov; 2012 Jun; 2(6):495-502. PubMed ID: 22614325
[TBL] [Abstract] [Full Text] [Related]
6. The influence of lymphangiography on the development of hypothyroidism in patients irradiated for Hodgkin's disease.
Fein DA; Hanlon AL; Corn BW; Curran WJ; Coia LR
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):13-8. PubMed ID: 8823254
[TBL] [Abstract] [Full Text] [Related]
